Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 3 | — | IM |
She has experienced long COVID herself; This spontaneous case was reported by a patient and describes the occurrence of POST-ACUTE COVID-19 SYNDROME (She has experienced long COVID herself) in a 72-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received first dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, received second dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) dosage was changed to 1 dosage form and third dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) dosage was changed to 1 dosage form. On an unknown date, the patient experienced POST-ACUTE COVID-19 SYNDROME (She has experienced long COVID herself). At the time of the report, POST-ACUTE COVID-19 SYNDROME (She has experienced long COVID herself) outcome was unknown. No concomitant medications were reported. The patient had experienced long COVID herself and noted that there was no test available to diagnose it. She wanted to know if there were any specific studies for a long COVID because nobody seemed to have any idea what to do with long COVID. She had not switched companies at any point. She had consistently received the same Moderna vaccine over the past couple of years. Also, she mentioned it was not anyone's fault. It was unknown if the patient experienced any additional symptoms/events. No treatment information was provided. Reporter did not allow further contact